BackNemaura Medical Overview

Nemaura Medical Net Income

Latest net income for NMRD: $-6.3M, below the Healthcare sector average of $1.5T.

Get informed when a big investor buys or sells

+ Follow

Quarterly Net Income

-$2.16M
↑ 22.78% YoY

As of Dec 2023

Annual Net Income (TTM)

-$6.30M
↑ 67.91% YoY

Trailing 12 months ending Dec 2023

Average Net Income (Comparison Companies)

Loading

Net Income History

Loading

Net Income Comparison

Loading

Annual Net Income Growth Rate (%)

Loading...

Annual Net Income Growth (Absolute)

Loading...

Nemaura Medical (NMRD) FAQ

The latest net income for NMRD is $-6.3M as of December 2023. That compares with $-20M in the prior-year period — up 67.9% year over year. That is below the Healthcare sector average of $1.5T. Investors often review this figure alongside Nemaura Medical's historical trend and sector peers before judging valuation or financial health.

Over the past year, NMRD's net income moved from $-20M to $-6.3M — a 67.9% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Nemaura Medical's operating scale or balance-sheet position.

Against Healthcare companies, NMRD currently prints $-6.3M for net income, while the sector average sits near $1.5T. That is roughly 100.0% below the sector mean. Large gaps often invite a closer look at Nemaura Medical's growth, margins, and balance sheet.

A net income figure of $-6.3M for NMRD is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. The Healthcare average is about $1.5T. Explore the charts below for those layers of context.

After noting NMRD's net income ($-6.3M), review year-over-year change from $-20M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.